T-cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas
Gliomas are intrinsic brain tumors with a high degree of constitutive and acquired resistance to standard therapeutic modalities such as radiotherapy and alkylating chemotherapy. Glioma subtypes are recognized by characteristic mutations. Some of these characteristic mutations have shown to generate...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 January 2022
|
| In: |
Clinical cancer research
Year: 2022, Volume: 28, Issue: 2, Pages: 378-389 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-21-1881 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-21-1881 Verlag, lizenzpflichtig, Volltext: https://clincancerres.aacrjournals.org/content/early/2021/11/01/1078-0432.CCR-21-1881 |
| Author Notes: | Michael Kilian, Mirco Friedrich, Khwab Sanghvi, Edward Green, Stefan Pusch, Daisuke Kawauchi, Martin Löwer, Jana K. Sonner, Christopher Krämer, Julia Zaman, Stefanie Jung, Michael O. Breckwoldt, Gerald Willimksy, Stefan B. Eichmüller, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten, and Lukas Bunse |
| Summary: | Gliomas are intrinsic brain tumors with a high degree of constitutive and acquired resistance to standard therapeutic modalities such as radiotherapy and alkylating chemotherapy. Glioma subtypes are recognized by characteristic mutations. Some of these characteristic mutations have shown to generate immunogenic neoepitopes suitable for targeted immunotherapy. |
|---|---|
| Item Description: | Published first November 15, 2021 Gesehen am 20.01.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-21-1881 |